**Trader consensus on this market reflects the substantial technical, diplomatic, and political barriers to any non-nuclear US ally acquiring nuclear weapons in the remaining months before 2027.** Most US allies remain committed to the Nuclear Non-Proliferation Treaty (NPT), and none have active indigenous weapons programs advancing toward completion on this compressed timeline. Extended US nuclear deterrence commitments, reinforced through alliance structures like NATO and bilateral security pacts in Asia, continue to serve as the primary reassurance mechanism against regional threats from actors such as North Korea, China, or Russia. Recent developments have included heightened regional security concerns prompting public debate in South Korea and Japan over nuclear options or hedging strategies, alongside US discussions of nuclear-powered submarine cooperation. However, credible reporting shows these remain at the level of policy discussion or capability enhancement short of weaponization, with no confirmed shifts toward independent arsenals. The February 2026 expiration of New START has focused attention on US-Russian strategic modernization rather than allied proliferation. Analyses from nonpartisan sources consistently note that moving from current postures to a deliverable nuclear capability would require overcoming significant hurdles in fissile material production, testing, delivery systems, and international opposition—steps that historical precedents indicate take years rather than months. No primary-source announcements, official actions, or verified technical milestones in the past 30 days indicate an imminent breakthrough for any qualifying ally. While late-breaking diplomatic realignments or crises could theoretically alter trajectories, the current evidence supports the market’s strong weighting toward “No.”